Pneumonia and HIV Types: A Case Control Study in Gadarif State, Sudan
DOI:
https://doi.org/10.14738/jbemi.96.13442Keywords:
Pneumonia, HIV types, Bacterial opportunistic infections.Abstract
Background: Pulmonary infections remain one of the most important causes of morbidity and mortality among HIV patients, and the first cause of hospital admission in the HAART era. Achieving an etiological diagnosis of pulmonary infection in these patients is important due to its prognostic consequences. This is a case control study conducted at ART Center in Gedarif Teaching Hospital between the periods January 2020 to October 2021. Oro pharyngeal swabs were collected for isolation and identification of organisms from fifty HIV patients suffering from pneumonia with ages from 15 years old to 65 years old were included in this study to elicit the microorganism insulted to pneumonia among them. And also to detect types of HIV which are most associated with those pneumonic patients. Results: The results revealed that all pneumonic patients were type (1) HIV patients (100%), the most common microorganisms isolated were Staphylococcus auras (60%), Haemophilus influenzeae (20%), Pseudomonas aerugnosa (18%),and Streptococcus pneumonia (2%). Conclusion: This study indicated that all HIV patients are type 1, and revealed that the most common cause of pneumonia in HIV infected patients was Staphylococcus auras. So Accurate diagnosis, and appropriate treatment and prevention of HIV-associated opportunistic pneumonias is an important strategy for reducing the morbidity and mortality associated with HIV/AIDS.
References
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30. https ://doi.org/10.3322/caac.21442
Azoulay E, Mokart D, Kouatchet A et al (2019) Acute respiratory failure in immunocompromised adults. Lancet Respir Med 7:173–186. https :// doi.org/10.1016/S2213 -2600(18)30345 -X
Contejean A, Lemiale V, Resche-Rigon M et al (2016) Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco Hématologique (Grrr-OH) study. Ann Intensive Care 6:102. https ://doi.org/10.1186/s1361 3-016-0202-0
Bauer PR, Chevret S, Yadav H et al (2019) Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy. Eur Respir J. https ://doi.org/10.1183/13993 003.02442 -
Azoulay E, Mokart D, Lambert J et al (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182:1038–1046. https ://doi.org/10.1164/rccm.20100 1-0018O C
Evangelatos N, Satyamoorthy K, Levidou G et al (2018) Multi-Omics Research Trends in Sepsis: a Bibliometric, Comparative Analysis Between the United States, the European Union 28 Member States, and China. OMICS 22:190–197. https ://doi.org/10.1089/omi.2017.0192
Centers for Disease Control and Prevention (CDC). Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep 1981; 30: 250–252.
Global report: UNAIDS report on the global AIDS epidemic 2010. www.unaids.org/globalreport/documents/20101123_GlobalReport _full_en.pdf Date last accessed: July 7, 2011.
Grubb JR, Moorman AC, Baker RK, et al. The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS 2006; 20: 1095–1107.
Torres RA, Barr M. Impact of combination therapy for HIV infection on inpatient census. N Engl J Med 1997; 33: 1531–1532.
Sobrino-Vegas P, Garcı´a-San Miguel L, Caro-Murillo AM, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res 2009; 7: 224–230.
Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med 2008; 16: 156–161.
Afessa B, Greaves W, Gren W, et al. Autopsy findings in HIVinfected inner city patients. J Acquir Immune Defic Syndr 1992; 5:132–136.
Miller R. HIV-associated respiratory diseases. Lancet 1996; 348: 307–312.
Feikin DR, Feldman C, Schuchat A, et al. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004; 4: 445–455.
Lazarous DG, O’Donnell AE. Pulmonary infections in the HIVinfected patient in the era of highly active antiretroviral therapy: an update. Curr Infect Dis Rep 2007; 9: 228–232.
Benito N, Ran˜ o´ A, Moreno A, Pulmonary infiltrates in HIVinfected patients in the highly active antiretroviral therapy in Spain. J Acquir Immune Defic Syndr 2001; 27: 35–43.
Benito N, Moreno A, Filella X, et al. Inflammatory responses in blood samples of human immunodeficiency virus infected patients with pulmonary infections. Clin Diagn Lab Immunol 2004; 11: 608–614.
Whalen C, Horsburgh CR, Hom D, et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129–135.
Kohli R, Lo Y, Homel P, et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis 2006; 43: 90–98. 48
Del Amo J, Perez-Hoyos S, Herna´ndez Aguado I, et al. Impact of tuberculosis on HIV disease progression in persons with welldocumented time of HIV seroconversion. J Acquir Immune Defic Syndr 2003; 33: 184–19
Klndu Alem, Prevalence of bacterial pneumonia among HIV-Seropositive patients in East Africa: Review, Cogent Medicine (2021), 8: 2015883 https://doi.org/10.1080/2331205X.2021.2015883
Gordin FM, Roediger MP, Girard PM, et al. Pneumonia in HIV infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 2008; 178: 630–636.
Morris AM, Huang L, Bacchetti P, et al. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 2000; 162: 612–616.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Salwa Abdelrahman Hamd Elbashir, A. D. Abakar, Bakri Y. M. Nour
This work is licensed under a Creative Commons Attribution 4.0 International License.
